Applied DNA Sciences Completes Second International Trial of SigNature® T to Protect Cotton: Successful DNA-Marking of Cotton on Foreign Soil

Share Article

The trial, in collaboration with one of the world's foremost textile organizations displayed the capacity of the APDN platform for use in protecting massive national cotton crops from counterfeiting and dilution.

Applied DNA Sciences, Inc. (OTCQB: APDN), (Twitter: @APDN), a provider of DNA-based anti-counterfeiting technology and product authentication solutions, today announced the success of a large-scale trial of its new SigNature T anti-counterfeiting platform to assure identity and originality of textiles and apparel. The trial, in collaboration with one of the world’s foremost textile organizations, displayed the capacity of the APDN platform for use in protecting massive international cotton crops from counterfeiting and dilution.

The announcement was the second involving the use of the company’s new SigNature T platform for textiles and apparel. The first, announced last week, revealed an agreement between the APDN and Supima, the industry association promoting luxury America Pima Cotton. The trial announced today is separate from the Supima project, and took place on foreign soil. Both parties agreed not to reveal the location of the trial at this time.

In the trial, an uncopyable SigNature DNA mark of authenticity was applied to five tons of the finest Extra Long Staple (ELS) cotton. APDN scientists were able to detect the difference between real and fake in every test at each major step of the cotton logistics chain, from ginning, through roving, through finished product. The APDN mark survived despite aggressive processing, industrial washing, and other harsh treatments and stresses.

While ultra high quality cotton fiber retains its cachet as a luxury product, a rising tide of counterfeit cotton cloth threatens the integrity and worldwide sales of the fiber. These threats include the sale of cheap cotton posing as the real thing, and the theft of intellectual property such as internationally patented logos, labels and brands.

The SigNature T platform has been made possible by a proprietary (patent pending) breakthrough technology, recently developed by the company to identify textile raw materials as well as finished products. New binding and extraction techniques have enabled an extremely cost-effective, even more flexible and robust anti-counterfeiting and anti-diversion protection for textiles and apparel, including military protective wear. Fibers, yarn, fabric, garments and labels are marked with unique, secure and enduring SigNature DNA that can be definitively authenticated at any point in the supply chain.

Commented Dr. James Hayward, CEO and President of Applied DNA Sciences:

“We believe that the great success of this trial shows that the APDN anti-counterfeiting platform for textiles will be the worldwide gold standard for brand identity assurance in textiles. APDN can now mark massive volumes of product, on both American and foreign soils, and assure integrity of the textile supply chain at an unprecedented level.”

About Applied DNA Sciences

APDN is a provider of botanical-DNA based security and authentication solutions that can help protect products, brands and intellectual property of companies, governments and consumers from theft, counterfeiting, fraud and diversion. SigNature® DNA and DNANet®, our principal anti-counterfeiting and product authentication solutions that essentially cannot be copied, provide a forensic chain of evidence and can be used to prosecute perpetrators.

The statements made by APDN may be forward-looking in nature. Forward-looking statements describe APDN’s future plans, projections, strategies and expectations, and are based on assumptions and involve a number of risks and uncertainties, many of which are beyond the control of APDN. Actual results could differ materially from those projected due to our short operating history, limited financial resources, limited market acceptance, market competition and various other factors detailed from time to time in APDN’s SEC reports and filings, including our Annual Report on Form 10-K, filed on December 20, 2012 and our subsequent quarterly reports on Form 10-Q. APDN undertakes no obligation to update publicly any forward-looking statements to reflect new information, events or circumstances after the date hereof to reflect the occurrence of unanticipated events.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Mitchell Miller

Mitchell Miller
Visit website